Roche (RHHBY.PK) has entered into an alliance with the Belgian biotech company Galapagos to develop new therapies for the treatment of chronic obstructive pulmonary disease (COPD). While Galapagos will be responsible for the development of COPD targets and drug candidates for these targets, Roche will have an exclusive option to license each Galapagos development program ...